Registration is open for our 2026 Annual General Meeting
RegisterViewPress releases, company updates, and media coverage.
Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations
Read the release
This morning we announced results from our exploratory human Quicksome™ testosterone study, and I am pleased to share why I believe this work represents an important step for the Company.
Read the update
Mountain Valley MD Holdings Inc. (MVMD) recently reported positive results from ongoing citrus field trials in Brazil for its Agrarius™ signaling technology.
Read the story
New press releases and company updates, sent as they publish. No noise.
We only use your email to send newsroom updates. Unsubscribe anytime. Privacy policy
Company Update
Up to 32.5% more special-grade yield and 27.6% more total yield versus control. The independently designed and conducted Brazilian trial showed the strongest Agrarius program adding 8.0 tonnes per hectare in the higher-value 45 to 70 mm category, lifting special-grade share to about 80.7% of total yield versus 76.4% in the control.
Dennis H.
Press Release
Independent randomized field trial recorded numerical increases of up to 32.5% in special-grade potato yield and up to 27.6% in total yield in the leading Agrarius application programs.
Press Release
The More Life Company (formerly MVMD), announces the completion of its corporate name change and is pleased to announce that its common shares will continue to be quoted on the OTCID under the new trading symbol “TMLCF”.
Company Update
This morning, we announced the completion of our corporate name change from Mountain Valley MD to The More Life Company.
Dennis H.
Press Release
The More Life Company, formerly Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTC: MVMDF), is pleased to announce that it has completed a corporate name change.
Company Update
This morning we announced the appointment of five additional advisors to MVMD,
Dennis H.
Press Release
The Company has appointed the five individuals listed below as advisors to provide strategic advisory services to the Company.
Company Update
Quicksome™ Technology and the Emerging Peptide Opportunity
Dennis H.
Press Release
Mountain Valley MD advances QuickSome™ sublingual delivery platform for compounded peptide applications, reports on initial formulation work across multiple peptides including BPC-157
Company Update
Dennis H.
Press Release
Press Release
Tell us a little about your organization and what you are interested in exploring.